PTCT Ptc Therapeutics, Inc.

$78.92 +0.60%

Healthcare · Pharmaceutical Preparations

Ptc Therapeutics, Inc. (PTCT) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $655 million. Shares last traded at $78.92, 9.6% below their 52-week high. Over the past year the stock is up 55.2%. PTCT trades at a price-to-earnings ratio of 0.96, below the Pharmaceutical Preparations median of 16.82. Net profit margin is 39.5%, above the peer median of -0.1%. Revenue grew 114.5% year over year.

Market Cap

$655M

Shares Out

8.3M

EPS (TTM)

$28.75

P/E Ratio

2.75

P/S Ratio

0.38

P/B Ratio

—

Dividend / Share

—

Dividend Yield

—

52-Week High

$87.29

52-Week Low

$43.19

Volume

63,049

Avg Vol (3m)

63,884.317

Performance

+5.64%

+12.23%

+17.60%

+4.60%

YTD

+2.85%

+55.20%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

63.58

SMA (50)

$71.01

SMA (200)

$70.28

Price vs SMA50

+11.14%

Price vs SMA200

+12.29%

ATR (14)

$3.31

Financials

Revenue

$1.7B

Net Income

$683M

Gross Margin

—

Operating Margin

50.1%

Net Margin

39.5%

Return on Equity

-378.5%

Return on Assets

23.8%

Current Ratio

2.44

Debt / Equity

-1.58

Revenue Growth (YoY)

+114.5%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.03	2026-05-07
FY 2025	$7.78	2026-02-19
Q3 2025	$9.45	2025-11-04
Q2 2025	$9.29	2025-08-07
Q1 2026	$10.04	2026-05-07
FY 2025	$-4.73	2026-02-19

Full earnings history →

Pharmaceutical Preparations peers

PTCT vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

0.96 / 16.82 med

-94% discount

P/S vs peers

0.38 / 3.54 med

-89% discount

Net margin vs peers

39.5% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.